Literature DB >> 32360140

Bee venom and SARS-CoV-2.

Wei Yang1, Fu-Liang Hu2, Xiao-Feng Xu3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32360140      PMCID: PMC7190514          DOI: 10.1016/j.toxicon.2020.04.105

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


× No keyword cloud information.
According to data from Johns Hopkins Coronavirus Resource Center, the global number of confirmed COVID-19 case exceeded 2.0 million on the 15th of April. I am a physician, and I participated the prevention and control of coronavirus in China. There is one discovery we would like to report here. It reminds us the story of the discovery of cowpox and the eventual victory of humans over this disease (Bennett and Baxby, 1996). In Hubei province, the epicentre of COVID-19 in China, the local beekeepers association conducted a survey of beekeepers (Fig. 1 ). A total of 5115 beekeepers were surveyed from February 23 to March 8, including 723 in Wuhan, the outbreak epicentre of Hubei. None of these beekeepers developed symptoms associated with COVID-19, and their health was totally normal. After that, we interviewed five apitherapists in Wuhan and followed 121 patients of their apitherapy clinic. These patients had received apitherapy from October 2019 to December 2019, and all the five bee apitherapists have the habit of self-apitherapy for their own health care (apitherapy means making use of bee venom from the honeybee's sting to treat or prevent certain diseases). Without any protective measures, two of the five apitherapists were exposed to suspected COVID-19 cases and others were exposed to confirmed COVID-19 cases, but none of them were infected eventually. None of the 121 patients were infected by SARS-CoV-2, and three of them had close contact with immediate family members who were confirmed SARS-CoV-2 Infection cases. It might be supposed that beekeepers are less likely to be exposed to SARS-CoV-2 because they live in less densely populated rural areas. But the five apitherapists and their patients are from densely populated areas in Wuhan. These people have one thing in common: they develop a tolerance to bee sting.
Fig. 1

Investigation histogram of beekeepers in Hubei.

Investigation histogram of beekeepers in Hubei. Bee sting can cause allergic reactions (Park and Lee, 2016), and it can even lead to death due to the excessive stress response of the immune system (Vazquez-Revuelta and Madrigal-Burgaleta, 2018). Bee venom can affect the body's immune system (Cherniack and Govorushko, 2018) and enhance the differentiation of human regulatory T cells (Caramalho et al., 2015), which play an important role in control of SARS-CoV infection (Chen et al., 2010). Does the stimulation of the immune system caused by bee venom reduce susceptibility to SARS-CoV-2? To test this, animal experiments would be needed. Monkeys might be suitable for this study. Monkeys could be divided into two experimental groups with the same breed and age. One group could be made tolerant to bee venom after a period of daily bee stings, while the other group receives no intervention. They could then be raised in the same environment contaminated by SARS-CoV-2, and multiple tests performed to see if they were infected by SARS-CoV-2. Our purpose in writing this letter is to ask scholars with appropriate research conditions to test this assumption. In the absence of vaccine of SARS-CoV-2, if this method works, then it could offer one hope towards victory over COVID-19.

Ethical statement

The research conforms to moral and ethical norms. Project number of the funding: 0020190293.

Declaration of competing interest

The authors have no conflicts of interest to declare. The survey data of beekeepers in Hubei province were provided by professor Fu-liang Hu, an expert of apiology. Dr. Xu gave me a lot of support on my task of the prevention and control of coronavirus.
  6 in total

1.  Bee venom enhances the differentiation of human regulatory T cells.

Authors:  I Caramalho; A Melo; E Pedro; M M P Barbosa; R M M Victorino; M C Pereira Santos; A E Sousa
Journal:  Allergy       Date:  2015-07-30       Impact factor: 13.146

Review 2.  Cowpox.

Authors:  M Bennett; D Baxby
Journal:  J Med Microbiol       Date:  1996-09       Impact factor: 2.472

Review 3.  To bee or not to bee: The potential efficacy and safety of bee venom acupuncture in humans.

Authors:  E Paul Cherniack; Sergey Govorushko
Journal:  Toxicon       Date:  2018-09-28       Impact factor: 3.033

4.  Granulomatous Inflammation Induced by Bee Sting.

Authors:  Hye Sun Park; Jeong Hyun Lee
Journal:  JAMA Ophthalmol       Date:  2016-08-11       Impact factor: 7.389

5.  Death due to Live Bee Acupuncture Apitherapy.

Authors:  P Vazquez-Revuelta; R Madrigal-Burgaleta
Journal:  J Investig Allergol Clin Immunol       Date:  2018       Impact factor: 4.333

6.  Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection.

Authors:  Jun Chen; Yuk Fai Lau; Elaine W Lamirande; Christopher D Paddock; Jeanine H Bartlett; Sherif R Zaki; Kanta Subbarao
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

  6 in total
  9 in total

Review 1.  Pharmacological effects and mechanisms of bee venom and its main components: Recent progress and perspective.

Authors:  Peiying Shi; Shihui Xie; Jiali Yang; Yi Zhang; Shuo Han; Songkun Su; Hong Yao
Journal:  Front Pharmacol       Date:  2022-09-27       Impact factor: 5.988

2.  Some natural hypomethylating agents in food, water and environment are against distribution and risks of COVID-19 pandemic: Results of a big-data research.

Authors:  Mohammad Reza Besharati; Mohammad Izadi; Alireza Talebpour
Journal:  Avicenna J Phytomed       Date:  2022 May-Jun

Review 3.  Bee Venom-A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections.

Authors:  Keneth Iceland Kasozi; Gniewko Niedbała; Mohammed Alqarni; Gerald Zirintunda; Fred Ssempijja; Simon Peter Musinguzi; Ibe Michael Usman; Kevin Matama; Helal F Hetta; Ngala Elvis Mbiydzenyuy; Gaber El-Saber Batiha; Amany Magdy Beshbishy; Susan Christina Welburn
Journal:  Front Public Health       Date:  2020-12-10

4.  Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-2.

Authors:  Masoumeh Sadat Mousavi Maleki; Mosayeb Restamian; Hamid Madanchi
Journal:  Expert Rev Anti Infect Ther       Date:  2021-04-12       Impact factor: 5.091

Review 5.  COVID-19 pandemic: impacts on bees, beekeeping, and potential role of bee products as antiviral agents and immune enhancers.

Authors:  Youssef A Attia; Gianpaolo M Giorgio; Nicola F Addeo; Khalid A Asiry; Giovanni Piccolo; Antonino Nizza; Carmelo Di Meo; Naimah A Alanazi; Adel D Al-Qurashi; Mohamed E Abd El-Hack; Asmaa F Khafaga; Fulvia Bovera
Journal:  Environ Sci Pollut Res Int       Date:  2022-01-07       Impact factor: 4.223

Review 6.  New Insights into Potential Beneficial Effects of Bioactive Compounds of Bee Products in Boosting Immunity to Fight COVID-19 Pandemic: Focus on Zinc and Polyphenols.

Authors:  Meryem Bakour; Hassan Laaroussi; Driss Ousaaid; Asmae El Ghouizi; Imane Es-Safi; Hamza Mechchate; Badiaa Lyoussi
Journal:  Nutrients       Date:  2022-02-23       Impact factor: 5.717

Review 7.  Melittin-Based Nano-Delivery Systems for Cancer Therapy.

Authors:  Anqi Wang; Yuan Zheng; Wanxin Zhu; Liuxin Yang; Yang Yang; Jinliang Peng
Journal:  Biomolecules       Date:  2022-01-12

8.  Chemical, Cytotoxic, and Anti-Inflammatory Assessment of Honey Bee Venom from Apis mellifera intermissa.

Authors:  Iouraouine El Mehdi; Soraia I Falcão; Mustapha Harandou; Saïd Boujraf; Ricardo C Calhelha; Isabel C F R Ferreira; Ofélia Anjos; Maria G Campos; Miguel Vilas-Boas
Journal:  Antibiotics (Basel)       Date:  2021-12-10

Review 9.  Harnessing the Natural Toxic Metabolites in COVID-19.

Authors:  Ali Bahrami; Mohammad Taheri; Mohammad Reza Arabestani; Meysam Soleimani; Mojdeh Mohammadi; Fatemeh Golabchi; Maryam Banitorfi; Seyed Mostafa Hosseini; Sodabe Khodabandehlou; Fatemeh Nouri
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-07       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.